Drug intelligence / Profile preview

yiqi yangyin huoxue lishui

Development stage
Unknown
Lead developer
Aier Eye Hospital
Administration
Oral
01

Overview

Yiqi Yangyin Huoxue Lishui is a Traditional Chinese Medicine (TCM) formula utilized by Chongqing Aier Eye Hospital for the treatment of diabetic macular edema (DME). The formula's name reflects its core therapeutic principles in TCM: supplementing Qi (Yiqi), nourishing Yin (Yangyin), promoting blood circulation to resolve stasis (Huoxue), and inducing diuresis to alleviate edema (Lishui). In clinical research, it is evaluated as an adjunctive therapy alongside anti-VEGF agents like aflibercept. The formula is designed to address the underlying pathological patterns of Qi and Yin deficiency and blood stasis, which are believed to contribute to retinal microvascular leakage and fluid accumulation in diabetic retinopathy. By improving microcirculation and promoting the absorption of subretinal fluid, the formula aims to enhance visual acuity and reduce central macular thickness in patients with DME.

Other names
Yiqi Yangyin Huoxue Lishui decoctionYiqi Yangyin Huoxue Lishui formula
02

Targets

ACE (Angiotensin Converting Enzyme)

Beyond the preview

Go deeper on yiqi yangyin huoxue lishui.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on yiqi yangyin huoxue lishui.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call